Your browser doesn't support javascript.
loading
Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe, Hill L; Boyer, Taylor L; Shipherd, Jillian C; Kauth, Michael R; Jasuja, Guneet K; Blosnich, John R.
Afiliação
  • Wolfe HL; Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
  • Boyer TL; Pain Research, Informatics, Multi-morbidities, and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, USA.
  • Shipherd JC; Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USA.
  • Kauth MR; Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
  • Jasuja GK; Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Health Program, Veterans Health Administration, Washington D.C., USA.
  • Blosnich JR; Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Ann Behav Med ; 57(12): 1014-1023, 2023 11 16.
Article em En | MEDLINE | ID: mdl-37436725
Veterans Health Administration (VHA) policy mandates the provision of several gender-affirming health services, including gender-affirming hormone therapy (GAHT). GAHT can improve quality of life among transgender and gender diverse (TGD) patients by more closely aligning their physical self with their internal sense of self. We conducted interviews with 30 TGD patients and 22 VHA healthcare providers to gather their perspectives on barriers and facilitators to GAHT in the VHA. Findings revealed that facilitators of GAHT access included information sharing through social networks and relying on providers in primary care or specialized TGD health clinics for prescribing, while barriers included a shortage of trained providers and patient dissatisfaction with prescribing practices. Anticipating or experiencing stigma from providers and other patients was also identified as a barrier to GAHT. To overcome barriers, participants recommended increasing provider capacity, offering continuous education on GAHT prescribing, and improving communication about VHA policies and training. Comprehensive improvements at various levels, both within and outside the VHA, are necessary to improve access to this important evidence-based treatment for TGD patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Transgênero / Minorias Sexuais e de Gênero Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Ann Behav Med Assunto da revista: CIENCIAS DO COMPORTAMENTO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Transgênero / Minorias Sexuais e de Gênero Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Ann Behav Med Assunto da revista: CIENCIAS DO COMPORTAMENTO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos